Quick answers
- What is TOBI Podhaler?
- TOBI Podhaler is a brand name of Tobramycin, a prescription medicine. The FDA NDC Directory lists 1 TOBI Podhaler product in 1 strength and form.
- Who makes TOBI Podhaler?
- Viatris holds the FDA application for TOBI Podhaler (NDA201688, approved March 22, 2013).
- Is there a generic or store brand of TOBI Podhaler?
- Other products of Tobramycin are listed with the FDA, but none in exactly the same strength and form as a TOBI Podhaler product.
- Has TOBI Podhaler been recalled?
- No recall linked to TOBI Podhaler products (by their NDC code or label) appears in the FDA enforcement reports we use.
What TOBI Podhaler is
Each TOBI Podhaler product as listed in the FDA NDC Directory, by active ingredient, strength and form, with its official label. “Same medicine, other names” counts the other products with exactly the same active ingredients, strength and form (generic versions, store brands and other brands); inactive ingredients can differ.
Tobramycin · prescription medicine
| Strength and form | Product names | Same medicine, other names | Label |
|---|---|---|---|
| tobramycin 28 mg capsule (oral, respiratory (inhalation)) | TOBI Podhaler | None listed | DailyMed |
Its page lists every product and company, the FDA label’s uses and boxed warning, approvals, shortages and recalls: Tobramycin →
FDA approval
- NDA: New Drug Application: how a new (usually brand-name) medicine is approved.
| Application | Holder | First approved | Products |
|---|---|---|---|
| NDA201688 | Viatris | March 22, 2013 | 1 |
Companies that list TOBI Podhaler
The company named on the package (holder, repackager or distributor), as listed in the FDA NDC Directory, with its number of TOBI Podhaler products.
- Viatris Specialty LLC1 product
Recalls
No recall linked to TOBI Podhaler products (by their NDC code or label) appears in the FDA enforcement reports.
Sources
- NDC Directory (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drugs@FDA (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drug labeling (SPL, openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drug recall enforcement reports (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 27, 2026, retrieved October 31, 2026
- NADAC (National Average Drug Acquisition Cost) 2026 — Centers for Medicare & Medicaid Services (CMS), data.medicaid.gov, list of November 4, 2026, retrieved November 7, 2026
Which names get a brand page: a name the NDC Directory lists for a medicine, held by one company (the FDA application holder, or the company named on most of its products), that is not just a description, and that is not the only product of its medicine.